高盐摄入量影响内脏脂肪组织恒温:GLP-1激动剂的有益作用
Vanessa Touceda1,2, Leonardo Cacciagiú2,3, Ignacio Barbani Moglie1
1Laboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Instituto de Investigaciones Biomédicas (UCA-CONICET), Facultad de Medicina, Pontificia Universidad Católica Argentina, Buenos Aires C1107AFF, Argentina.
Biology
|September 27, 2025
概括
高盐摄入损害内脏脂肪组织 (VAT) 功能,导致纤维化和氧化应激. 利拉格卢提德 (LGT) 治疗可以防止这些影响,这表明LGT是治疗盐引起的增值税功能障碍的方法.
科学领域:
- 代谢研究的研究.
- 脂肪组织生物学 脂肪组织生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高盐 (NaCl) 摄入量与内脏脂肪组织 (VAT) 功能障碍有关,独立于血压影响.
- 类似葡萄糖-1 (GLP-1) 激动剂,如利拉格卢提德 (LGT),呈现出潜在的治疗途径.
研究的目的:
- 调查慢性高盐饮食 (HSD) 对增值税平衡的影响.
- 评估LGT对HSD引起的增值税功能障碍的潜在保护作用.
主要方法:
- 雄性C57BL/6小鼠在15周内接受标准饮食或8%的NaCl HSD.
- 在HSD之后,小鼠接受了LGT或载体治疗5周.
- 增值税分析了组织学,原沉积,血管密度,线粒体动态,氧化应激和阿迪波金表达.
主要成果:
- HSD减少了体重,VAT质量和脂肪细胞大小,同时降低了血管密度和诱导纤维化.
- 与HSD相比,LGT治疗改善了血管化,增加了VEGF表达,减少了纤维化.
- 由HSD诱导的氧化应激和线粒体分裂被LGT减弱,LGT也使瘦素正常化,增加了阿迪波涅克水平.
结论:
- 过度食用盐会导致结构性和代谢性增值税功能障碍.
- LGT疗法减轻了HSD对VAT的几种不良影响,表明其在管理对盐敏感脂肪组织功能障碍方面的潜力.
相关概念视频
Glucagon-like Receptor Agonists
848
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
848
Dipeptidyl Peptidase 4 Inhibitors
594
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
594
Oral Hypoglycemic Agents: Biguanides and Glitazones
585
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
585
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
525
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
525
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Antihypertensive Drugs: Action of Diuretics
2.2K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.2K


